HeartWare International Insider Unloads $600,240 in Stock (HTWR)
HeartWare International (NASDAQ:HTWR) Insider Douglas Evan Godshall sold 8,000 shares of the company’s stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $75.03, for a total transaction of $600,240.00. Following the completion of the sale, the insider now directly owns 50,977 shares of the company’s stock, valued at approximately $3,824,804. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Several analysts have recently commented on the stock. Analysts at Canaccord Genuity reiterated a “buy” rating on shares of HeartWare International in a research note to investors on Monday, October 7th. They now have a $110.00 price target on the stock. Separately, analysts at Oppenheimer cut their price target on shares of HeartWare International from $95.00 to $89.00 in a research note to investors on Monday, October 7th. They now have a “market perform” rating on the stock. Finally, analysts at Raymond James cut their price target on shares of HeartWare International from $110.00 to $100.00 in a research note to investors on Monday, August 12th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $93.17.
HeartWare International (NASDAQ:HTWR) traded down 0.66% on Tuesday, hitting $75.42. The stock had a trading volume of 294,626 shares. HeartWare International has a 52-week low of $69.31 and a 52-week high of $99.68. The stock has a 50-day moving average of $75.80 and a 200-day moving average of $86.96. The company’s market cap is $1.241 billion.
HeartWare International (NASDAQ:HTWR) last announced its earnings results on Thursday, August 8th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by $0.06. Analysts expect that HeartWare International will post $-3.19 EPS for the current fiscal year.
Heartware International, Inc (NASDAQ:HTWR) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.